|
|
Volumn 348, Issue , 2014, Pages
|
|
Novel drug combination for tuberculosis to be tested across 50 sites.
a
a
NONE
(India)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HETEROCYCLIC COMPOUND;
MOXIFLOXACIN;
NITROIMIDAZOLE DERIVATIVE;
PYRAZINAMIDE;
QUINOLINE DERIVATIVE;
TUBERCULOSTATIC AGENT;
DRUG COMBINATION;
HUMAN;
METHODOLOGY;
NOTE;
PHASE 2 CLINICAL TRIAL (TOPIC);
TUBERCULOSIS;
ANTITUBERCULAR AGENTS;
AZA COMPOUNDS;
CLINICAL TRIALS, PHASE II AS TOPIC;
DRUG THERAPY, COMBINATION;
HUMANS;
NITROIMIDAZOLES;
PYRAZINAMIDE;
QUINOLINES;
TUBERCULOSIS;
|
|
EID: 84905093544
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.g3535 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
